52 participants
"Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial"
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-06
- Start Date:
- 2026-07-31
- Completion:
- 2027-07-31
Conditions
- Ascites Hepatic
Interventions
- DRUG
No Results Yet